EQUILLIUM, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EQUILLIUM, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $135.00K.
- EQUILLIUM, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $447.00K, a 1076.32% increase year-over-year.
- EQUILLIUM, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $1.19M.
- EQUILLIUM, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $38.00K.
- EQUILLIUM, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $1.83M, a 45675.00% increase from fiscal 2024.
- EQUILLIUM, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $4.00K.
- EQUILLIUM, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $891.00K, a 12628.57% increase from fiscal 2020.
- EQUILLIUM, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $7.00K, a 89.86% decline from fiscal 2019.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $135.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $447.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $1.83M 10-K · filed 2026-03-25 | |
| 2025-09-30 | $1.19M 10-Q · filed 2025-11-13 | |
| 2025-03-31 | $38.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $4.00K 10-K · filed 2026-03-25 | |
| 2021-12-31 | $891.00K 10-K · filed 2023-03-23 | |
| 2021-06-30 | $796.00K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $4.00K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $7.00K 10-K · filed 2022-03-23 | |
| 2019-12-31 | $69.00K 10-K · filed 2021-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |